As a Billionaire Activist Takes a Stake, Is Now the Time to Buy Pfizer Stock?
While Pfizer has made a number of acquisitions, its biggest bet is on Seagen. Pfizer wants this to be a transformative acquisition, and it projects Seagen to contribute $10 billion in sales by 2030. It said following the deal, it now has eight or more potential blockbuster drugs in its pipeline.
Activist investor Starboard has taken a $1 billion stake in Pfizer, according to a report, Super Micro stock surges, and ...
Pfizer's stock is poised for growth with strong technical and fundamental indicators, promising pipeline, and Seagen ...
Pfizer ( PFE 3.18%) stock jumped 3.1% through 11:20 a.m. ET Monday morning in response to a Wall Street Journal article over ...
Pfizer CEO Albert Bourla plans to meet key executives of activist hedge fund Starboard Value next week, the Financial Times ...
On top of this, Pfizer also faces key patent expirations of certain older products, and earlier estimated this will result in ...
Evan Seigerman, an analyst from BMO Capital, maintained the Buy rating on Pfizer (PFE – Research Report). The associated price target ...
U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Monday. Shares of Pfizer Inc PFE rose during ...
The Roundhill Magnificent Seven ETF — which holds Big Tech stocks including Nvidia, Apple Inc., Microsoft Corp, Alphabet Inc.
J.P. Morgan analyst Chris Schott maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $30.00. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback